Simvastatin induces apoptosis of cultured rat cardiomyocytes

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 12, Issue 4, 2001, Pages 325-338

  El Ani, Dalia ^a   Zimlichman, Reuven ^b  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

angiotensin II; caspase 3 activity; heart; Hoechst 3342

Indexed keywords

AGAROSE; ANGIOTENSIN; CASPASE 3; CREATINE KINASE; DNA FRAGMENT; FRUCTOSE BISPHOSPHATE ALDOLASE; HOE 33342; LACTATE DEHYDROGENASE; LIPOCORTIN 5; PROPIDIUM IODIDE; SIMVASTATIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL NUCLEUS; CELL SIZE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; HEART MUSCLE CELL; HYPERTROPHY; NONHUMAN; RAT;

ANGIOTENSIN II; ANIMALS; ANTICHOLESTEREMIC AGENTS; APOPTOSIS; CASPASE 3; CASPASES; CELLS, CULTURED; COLORING AGENTS; CREATINE KINASE; DNA; DNA FRAGMENTATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLOW CYTOMETRY; FRUCTOSE-BISPHOSPHATE ALDOLASE; L-LACTATE DEHYDROGENASE; MICROSCOPY, FLUORESCENCE; MYOCARDIUM; RATS; SIMVASTATIN;

EID: 0035721457     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.2001.12.4.325     Document Type: Article

References (37)

1. [No authors listed] Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) Lancet 1994; 344: 1383–1389.
2. Knapp, AC, Huang, J, Starling, G, Kiener, PA. Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death. Atherosclerosis 2000; 152: 217–227.
3. Kayikcioglu, M, Ozerkan, F, Soydan, I. Effectiveness and safety of alternate-day simvastatin and fenofibrate on mixed hyperlipidemia. Am J Cardiol 1999; 83: 1135–1137.
4. Shepherd, J, Cobbe, SM, Ford, I, Isles, CG, Lorimer, AR, MacFarlane, PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301–1307.
5. Ichihara, K, Satoh, K, Yamamoto, A, Hoshi, K. [Are all HMG-CoA reductase inhibitors protective against ischemic heart disease?] Nippon Yakurigaku Zasshi 1999; 114 Suppl 1:142P-149P. in Japanese.
6. Haria, M, McTavish, D. Pravastatin. A reappraisal of its pharmacological properties and clinical effectiveness in the management of coronary heart disease. Drugs 1997; 53: 299–336.
7. Grundy, SM, ed. Symposium: Role of Therapy with ‘Statins’ in Patients with Hypercholesterolemia. Am J Cardiol 1998; 81(4A): 1B-73B.
8. Keogh, A, Macdonald, P, Kaan, A, Aboyoun, C, Spratt, P, Mundy, J. Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation. J Heart Lung Transplant 2000; 19: 529–537.
9. Indolfi, C, Cioppa, A, Stabile, E, Di Lorenzo, E, Esposito, G, Pisani, A, et al. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury. J Am Coll Cardiol 2000; 35: 214–221.
10. Yeagle, PL. Lipid regulation of cell membrane structure and function. FASEB J 1989; 3: 1833–1842.
11. Vigano, T, Hernandez, A, Corsini, A, Granata, A, Belloni, P, Fumagalli, R, et al. Mevalonate pathway and isoprenoids regulate human bronchial myocyte proliferation. Eur J Pharmacol 1995; 291: 201–203.
12. Sahni, R, Maniet, AR, Voci, G, Banka, VS. Prevention of restenosis by lovastatin after successful coronary angioplasty. Am Heart J 1991; 121: 1600–1608.
13. Hidaka, Y, Eda, T, Yonemoto, M, Kamei, T. Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733). Atherosclerosis 1992; 95: 87–94.
14. Corsini, A, Mazzotti, M, Raiteri, M, Soma, MR, Gabbiani, G, Fumagalli, R, Paoletti, R. Relationship between mevalonate pathway and arterial myocyte proliferation: In vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis 1993; 101: 117–125.
15. 2+mobilization in vascular smooth muscle cells. J Cardiovasc Pharmacol 1996;27:383–391.
16. Gottlieb, RA, Burleson, KO, Kloner, RA, Babior, BM, Engler, RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994; 94: 1621–1628.
17. Hamet, P, Richard, L, Dam, TV, Teiger, E, Orlov, SN, Gaboury, L, et al. Apoptosis in target organs of hypertension. Hypertension 1995; 26: 642–648.
18. Teiger, E, Than, VD, Richard, L, Wisnewsky, C, Tea, BS, Gaboury, L et al. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest 1996; 97: 2891–2897.
19. Li, Z, Lakatta, EG, Robinson, KG, Bing, OH. Detection of apoptosis in the failing heart of spontaneously hypertensive rats. 68th Scientific Sessions of the American Heart Association. Anaheim, California, November 13–16, 1995. Abstract 1–526. Circulation 1995; 92 Suppl: IA-N, 11–944.
20. Kajstura, J, Cigola, E, Malhotra, A, Li, P, Cheng, W, Meggs, LG, Anversa, P. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997; 29: 859–870.
21. Bromme, HJ, Holtz, J. Apoptosis in the heart: When and why? Mol Cell Biochem 1996; 163-164:261-75.
22. Luo, JD, Zhang, WW, Zhang, GP. Guan, JX, Chen, X. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis. Clin Exp Pharmacol Physiol 1999; 26: 903–908.
23. Oi, S, Haneda, T, Osaki, J, Kashiwagi, Y, Nakamura, Y, Kawabe, J, Kikuchi, K. Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells. Eur J Pharmacol 1999; 376: 139–148.
24. El-Ani, D, Jacobson, KA, Shainberg, A. Regulation of A1 adenosine receptors by amiodarone and electrical stimulation in rat myocardial cells in vitro. Biochem Pharmacol 1997; 54; 583–587.
25. El-Ani, D, Jacobson, KA, Shainberg, A. Regulation of adenosine receptors in cultured heart cells. In: Sideman S, Beyar R, eds, Molecular and Subcellular Cardiology: Effects on Structure and Function. New York, NY, USA: Plenum Press; 202–215.
26. Guijarro, C, Blanco-Colio, LM. Ortego, M, Alonso, C, Ortiz, A, Plaza, JJ, et al. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenyl-ation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res 1998; 83: 490–500.
27. Baetta, R, Donetti, E, Comparato, C, Calore, M, Rossi, A, Teruzzi, C, et al. Proapoptotic effect of atorvastatin on stimulated rabbit smooth muscle cells. Pharmacol Res 1997; 36: 115–121.
28. Muller, C, Kiehl, MG. van de Loo, J, Koch, OM. Lovastatin induces p21WAF1/Cip1 in human vascular smooth muscle cells: Influence on protein phosphorylation, cell cycle, induction of apoptosis, and growth inhibition. Int J Mol Med 1999; 3: 63–68.
29. Mutoh, T, Kumano, T, Nakagawa, H, Kuriyama, M. Involvement of tyrosine phosphorylation in HMG-CoA reductase inhibitor-induced cell death in L6 myoblasts.FEBS Lett 1999; 444: 85–89.
30. Nagata, S. Apoptosis by death factor. Cell. 1997 7; 88: 355-65.
31. Goldstein, P. Cell death: TRAIL and its receptors. Curr Biol 7: R750-R753.
32. Meldrum, DR. Tumor necrosis factor in the heart. Am J Physiol 1998; 274: R577-R595.
33. Wallach, D, Kovalenko, AV, Varfolomeev, EE, Boldin, MP. Death-inducing functions of ligands of the tumor necrosis factor family: A Sanhedrin verdict. Curr Opin Immunol 1998; 10: 279–288.
34. Sadeghi, MM, Collinge, M, Pardi, R, Bender, JR. Simvastatin modulates cytokine-mediated endothelial cell adhesion molecule induction: Involvement of an inhibitory G protein. J Immunol 2000; 165: 2712–2718.
35. Di Napoli, P, Maggi, A, Spina, R, Barsotti, L, Taccardi, AA, Stuppia, L, et al. [Simvastatin and ischemia-reperfusion damage: Its effects on apoptotic myocyte death and on the endothelial expression of nitric— oxide synthetase in an experimental model of the isolated rat heart] Cardiologia. 1999; 44: 69–74. Italian.
36. 2+exchanger. FEBS Lett 1994; 343: 151–154.
37. Matzno, S, Yamauchi, T, Gohda, M, Ishida, N, Katsuura, K, Hanasaki, Y, et al. Inhibition of cholesterol biosynthesis by squalene epoxidase inhibitor avoids apoptotic cell death in L6 myoblasts. J Lipid Res 1997; 38: 1639–1648.